Physician profile
Sonia Rodriguez
NPI 1265806038
$10,323.14
in general payments reported to CMS, 2019-2025
20 companies · $2,503 in 2025
The $2,503 reported for 2025 was more than what 97% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,782 · 2022: $1,718 · 2023: $2,214 · 2024: $2,107 · 2025: $2,503.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,724 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,723.57 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $2,356.98 | 2021-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Astrazeneca Pharmaceuticals LP | $2,229.50 | 2021-2025 | Fasenra, Breztri, Airsupra |
| Mylan Specialty L.P. | $1,567.55 | 2021-2024 | Yupelri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $995.73 | 2021-2025 | Ofev, Jascayd |
| Genzyme Corporation | $855.37 | 2021-2025 | |
| Mallinckrodt Hospital Products INC. | $591.23 | 2021-2025 | Acthar |
| Actelion Pharmaceuticals US, INC. | $390.89 | 2021-2023 | Uptravi, Opsumit |
| Viatris Specialty LLC | $378.69 | 2025 | Yupelri |
| Insmed, INC. | $207.50 | 2021-2025 | Arikayce, Brinsupri |
| Regeneron Healthcare Solutions, INC. | $173.55 | 2021-2025 | Dupixent |
| Amgen INC. | $123.73 | 2023-2025 | Tezspire |
| Philips North America LLC | $117.19 | 2023-2025 | (8874) Incourage, Vest Therapy Und, (Ak6) Vest Therapy |
| Grifols USA, LLC | $111.91 | 2024-2025 | Prolastin-C Liquid |
| Ge Healthcare | $82.67 | 2023 | |
| United Therapeutics Corporation | $42.59 | 2025 | Tyvaso |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $24.93 | 2021-2023 | Xarelto |
| Vapotherm INC | $22.54 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $18.24 | 2021 | |
| Paratek Pharmaceuticals, INC. | $16.25 | 2021 | |
| Verona Pharma, INC. | $16.10 | 2025 | Ohtuvayre |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sonia Rodriguez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.